PortfoliosLab logo
DLB vs. QGEN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DLB and QGEN is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

DLB vs. QGEN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dolby Laboratories, Inc. (DLB) and Qiagen N.V. (QGEN). The values are adjusted to include any dividend payments, if applicable.

200.00%250.00%300.00%350.00%December2025FebruaryMarchAprilMay
294.86%
245.66%
DLB
QGEN

Key characteristics

Sharpe Ratio

DLB:

-0.07

QGEN:

0.07

Sortino Ratio

DLB:

0.11

QGEN:

0.30

Omega Ratio

DLB:

1.01

QGEN:

1.03

Calmar Ratio

DLB:

-0.06

QGEN:

0.05

Martin Ratio

DLB:

-0.22

QGEN:

0.19

Ulcer Index

DLB:

9.42%

QGEN:

9.53%

Daily Std Dev

DLB:

28.90%

QGEN:

26.06%

Max Drawdown

DLB:

-62.19%

QGEN:

-92.14%

Current Drawdown

DLB:

-23.66%

QGEN:

-24.61%

Fundamentals

Market Cap

DLB:

$7.19B

QGEN:

$9.32B

EPS

DLB:

$2.64

QGEN:

$0.38

PE Ratio

DLB:

28.36

QGEN:

113.50

PEG Ratio

DLB:

2.08

QGEN:

0.99

PS Ratio

DLB:

5.58

QGEN:

4.61

PB Ratio

DLB:

2.95

QGEN:

2.59

Total Revenue (TTM)

DLB:

$1.32B

QGEN:

$1.52B

Gross Profit (TTM)

DLB:

$1.17B

QGEN:

$692.87M

EBITDA (TTM)

DLB:

$121.80M

QGEN:

$201.34M

Returns By Period

In the year-to-date period, DLB achieves a -3.76% return, which is significantly lower than QGEN's -3.21% return. Over the past 10 years, DLB has outperformed QGEN with an annualized return of 7.88%, while QGEN has yielded a comparatively lower 5.90% annualized return.


DLB

YTD

-3.76%

1M

3.28%

6M

2.48%

1Y

-7.33%

5Y*

7.75%

10Y*

7.88%

QGEN

YTD

-3.21%

1M

12.73%

6M

0.05%

1Y

0.28%

5Y*

0.60%

10Y*

5.90%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DLB vs. QGEN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DLB
The Risk-Adjusted Performance Rank of DLB is 4343
Overall Rank
The Sharpe Ratio Rank of DLB is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of DLB is 3939
Sortino Ratio Rank
The Omega Ratio Rank of DLB is 3838
Omega Ratio Rank
The Calmar Ratio Rank of DLB is 4646
Calmar Ratio Rank
The Martin Ratio Rank of DLB is 4646
Martin Ratio Rank

QGEN
The Risk-Adjusted Performance Rank of QGEN is 4949
Overall Rank
The Sharpe Ratio Rank of QGEN is 5353
Sharpe Ratio Rank
The Sortino Ratio Rank of QGEN is 4444
Sortino Ratio Rank
The Omega Ratio Rank of QGEN is 4343
Omega Ratio Rank
The Calmar Ratio Rank of QGEN is 5353
Calmar Ratio Rank
The Martin Ratio Rank of QGEN is 5353
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DLB vs. QGEN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Dolby Laboratories, Inc. (DLB) and Qiagen N.V. (QGEN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for DLB, currently valued at -0.07, compared to the broader market-2.00-1.000.001.002.003.00
DLB: -0.07
QGEN: 0.07
The chart of Sortino ratio for DLB, currently valued at 0.11, compared to the broader market-6.00-4.00-2.000.002.004.00
DLB: 0.11
QGEN: 0.30
The chart of Omega ratio for DLB, currently valued at 1.01, compared to the broader market0.501.001.502.00
DLB: 1.01
QGEN: 1.03
The chart of Calmar ratio for DLB, currently valued at -0.06, compared to the broader market0.001.002.003.004.005.00
DLB: -0.06
QGEN: 0.05
The chart of Martin ratio for DLB, currently valued at -0.22, compared to the broader market-10.000.0010.0020.00
DLB: -0.22
QGEN: 0.19

The current DLB Sharpe Ratio is -0.07, which is lower than the QGEN Sharpe Ratio of 0.07. The chart below compares the historical Sharpe Ratios of DLB and QGEN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50December2025FebruaryMarchAprilMay
-0.07
0.07
DLB
QGEN

Dividends

DLB vs. QGEN - Dividend Comparison

DLB's dividend yield for the trailing twelve months is around 1.68%, less than QGEN's 2.92% yield.


TTM20242023202220212020201920182017201620152014
DLB
Dolby Laboratories, Inc.
1.68%1.57%1.29%1.45%0.96%0.91%1.15%1.08%0.94%1.11%1.25%0.23%
QGEN
Qiagen N.V.
2.92%2.88%0.00%0.00%0.00%0.00%0.00%0.00%3.42%0.00%0.00%0.00%

Drawdowns

DLB vs. QGEN - Drawdown Comparison

The maximum DLB drawdown since its inception was -62.19%, smaller than the maximum QGEN drawdown of -92.14%. Use the drawdown chart below to compare losses from any high point for DLB and QGEN. For additional features, visit the drawdowns tool.


-30.00%-25.00%-20.00%-15.00%-10.00%December2025FebruaryMarchAprilMay
-23.66%
-24.28%
DLB
QGEN

Volatility

DLB vs. QGEN - Volatility Comparison

The current volatility for Dolby Laboratories, Inc. (DLB) is 13.14%, while Qiagen N.V. (QGEN) has a volatility of 14.08%. This indicates that DLB experiences smaller price fluctuations and is considered to be less risky than QGEN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%December2025FebruaryMarchAprilMay
13.14%
14.08%
DLB
QGEN

Financials

DLB vs. QGEN - Financials Comparison

This section allows you to compare key financial metrics between Dolby Laboratories, Inc. and Qiagen N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M300.00M400.00M500.00M600.00M20212022202320242025
369.56M
521.20M
(DLB) Total Revenue
(QGEN) Total Revenue
Values in USD except per share items

DLB vs. QGEN - Profitability Comparison

The chart below illustrates the profitability comparison between Dolby Laboratories, Inc. and Qiagen N.V. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%20212022202320242025
90.3%
67.1%
(DLB) Gross Margin
(QGEN) Gross Margin
DLB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Dolby Laboratories, Inc. reported a gross profit of 333.72M and revenue of 369.56M. Therefore, the gross margin over that period was 90.3%.
QGEN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Qiagen N.V. reported a gross profit of 349.80M and revenue of 521.20M. Therefore, the gross margin over that period was 67.1%.
DLB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Dolby Laboratories, Inc. reported an operating income of 111.97M and revenue of 369.56M, resulting in an operating margin of 30.3%.
QGEN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Qiagen N.V. reported an operating income of 119.10M and revenue of 521.20M, resulting in an operating margin of 22.9%.
DLB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Dolby Laboratories, Inc. reported a net income of 91.79M and revenue of 369.56M, resulting in a net margin of 24.8%.
QGEN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Qiagen N.V. reported a net income of 88.32M and revenue of 521.20M, resulting in a net margin of 17.0%.